
Dan Tian was born in Huangshan, Anhui Province, China, in 1989.
Dan Tian received his M.D. and Ph.D. degree in Pathogenic Biology from Harbin Medical University as an eight-year Basic Medicine student in 2015.


He is currently an associated professor, associated researcher, and doctoral supervisor at Beijing Friendship Hospital, Capital Medical University.
He is also the vice director of the General Surgery Laboratory at the National Clinical Research Center for Digestive Diseases and a PI at State Key Lab of Digestive Health, Beijing Friendship Hospital.
Additionally, Dan Tian is an INTJ.
One aspect of his works focuses on the regulatory mechanisms and applications of a novel unconventional T cell subset, double negative T (DNT, CD3+TCRαβ+NK1.1–CD4−CD8−) cells, in autoimmunity and digestive diseases. His previous studies demonstrated that the adoptive transfer of DNT cells prevent immune-related diseases, such as allergic asthma (Nat Commun, 2019) and both systemic and local secondary inflammation induced by ischemic stroke (Theranostics, 2023).
Dan Tian’s recent research focuses on immune regulation mechanisms and their applications in inflammation and tumors of the digestive system. His team unraveled the NAD-induced intestinal T cell activation via P2X7R in postoperative ileus (Cell Immunol, 2023) and OX40-mediated aggravation of eosinophilic gastroenteritis through eosinophils (Front Immunol, 2022). He aims to further explore the elaborate roles of neurons and innate lymphocytes in the progression of digestive diseases.
Other Links
Personal introduction page in Graduate School of Capital Medical University (Chinese)
Personal Introduction page in the news of Beijing Friendship Hospital (Chinese)